The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 302.00
Bid: 301.50
Ask: 305.00
Change: -14.00 (-4.43%)
Spread: 3.50 (1.161%)
Open: 315.50
High: 315.50
Low: 302.00
Prev. Close: 316.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

30 Mar 2021 10:56

RNS Number : 9597T
Synthomer PLC
30 March 2021
 

LEI  213800EHT3TI1KPQQJ56

 

30 March 2021

 2020 Annual Financial Report and Notice of 2021 Annual General Meeting (AGM)

Copies of the Synthomer plc ("the Company") 2020 report and accounts, Notice of AGM (which will be held on 29 April 2021 at 12.00 noon) and associated proxy card have been sent to shareholders and submitted to the UK Listing Authority for publication through the National Storage Mechanism where they will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Final results for the year ended 31 December 2020 were announced on 4 March 2021. The 2020 report and accounts contain a responsibility statement by Mr C G MacLean, Chief Executive Officer, and Mr S G Bennett, Chief Financial Officer, by order of the Board, in the following form:

"Directors' confirmations

The Directors consider that the Annual Report and Accounts, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Group and Company's position and performance, business model and strategy.

Each of the Directors, whose names and functions are listed in the, Directors' Report confirm that, to the best of their knowledge:

· the Company financial statements, which have been prepared in accordance with United Kingdom AccountingStandards, comprising FRS 101 give a true and fair view of the assets, liabilities, financial position and profit of the Company; 

· the Group financial statements, which have been prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006, give a true and fair view of the assets, liabilities, financial position and profit of the Group; and

· the Directors' Report includes a fair review of the development and performance of the business and the position of the Group and Company, together with a description of the principal risks and uncertainties that it faces."

The 2020 report and accounts and Notice of AGM are also available on the Company's website, www.synthomer.com and upon request from the Company Secretary at 45 Pall Mall, London, SW1Y 5JG. 

 

Annual General Meeting and COVID-19

Current Government guidance, which is likely to apply at the time of this year's AGM on 29 April 2021 precludes indoor gatherings. We are therefore proposing to hold the AGM at our London head office with the minimum attendance required to form a quorum. We would always prefer to welcome shareholders in person to our AGMs. However, in the current circumstances, shareholders will not be permitted to attend the AGM but we would encourage all shareholders to vote by submitting the Form of Proxy which accompanies the Notice of Meeting. The results of the AGM will be announced as soon as practical following the meeting.

We meet with many shareholders during each year and we are always happy to answer any questions from shareholders. As shareholders consider voting ahead of the AGM and in the absence of being able to attend the AGM, we invite shareholders to submit any questions they may have by email to IR@synthomer.com. The Company's Board will endeavour to provide written answers to all questions submitted and make them available ahead of the Proxy submission deadline of 27 April 2021 by posting them on a dedicated 2021 Annual General Meeting page in the Investor Relations section of the Company website.

 

Our approach is based on the Government guidance published on 22 February 2021. Given the constantly evolving nature of the situation, should circumstances change before the time of the AGM, we will notify shareholders by announcement through the Regulatory News Service as early as possible before the date of the meeting and also post updates on the Company website at www.synthomer.com.

 

Tim Hughes, President, Corporate Development

Richard Atkinson, Company Secretary

 

 

Enquiries:

Synthomer plc

 

Tel: + 44 7764 859147

+ 44 7899 062411

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSGCGDXXUXDGBG
Date   Source Headline
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:55 pmRNSDirector/PDMR Shareholding
30th Jul 201912:54 pmRNSDirector/PDMR Shareholding
30th Jul 201912:53 pmRNSDirector/PDMR Shareholding
30th Jul 201912:52 pmRNSDirector/PDMR Shareholding
30th Jul 201912:51 pmRNSDirector/PDMR Shareholding
30th Jul 201912:50 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201911:31 amRNSResults of Rump Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.